Brief: Interpace Biosciences Announces CFO Leadership Transition
04/02/2021 23:21
Feb 4 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES ANNOUNCES CFO LEADERSHIP TRANSITION
* SAYS TOM FREEBURG APPOINTED CFO
* FREEBURG SUCCEEDS FRED KNECHTEL EFFECTIVE FEBRUARY 1,
2021.
Source text for Eikon: ID:nGNX7FJrwX
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million